Mina Kim - Net Worth and Insider Trading
Mina Kim Net Worth
The estimated net worth of Mina Kim is at least $2 Million dollars as of 2025-07-04. Mina Kim is the CEO of Acelyrin Inc and owns about 671,753 shares of Acelyrin Inc (SLRN) stock worth over $2 Million. Mina Kim is also the Chief Legal Officer of Zymergen Inc and owns about 298,427 shares of Zymergen Inc (ZY) stock worth over $725,178. Details can be seen in Mina Kim's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Mina Kim has not made any transactions after 2025-03-17 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Mina Kim
Mina Kim Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mina Kim owns 4 companies in total, including Atara Biotherapeutics Inc (ATRA) , Sunrun Inc (RUN) , and Zymergen Inc (ZY) among others .
Click here to see the complete history of Mina Kim’s form 4 insider trades.
Insider Ownership Summary of Mina Kim
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| ATRA | Atara Biotherapeutics Inc | 2018-04-09 | Senior VP & General Counsel |
| RUN | Sunrun Inc | 2016-03-03 | General Counsel |
| ZY | Zymergen Inc | 2022-09-02 | Chief Legal Officer |
 | | 2025-03-17 | Chief Legal & Admin. Officer |
Mina Kim Latest Holdings Summary
Mina Kim currently owns a total of 2 stocks. Among these stocks, Mina Kim owns 671,753 shares of Acelyrin Inc (SLRN) as of March 17, 2025, with a value of $2 Million and a weighting of 67.77%. Mina Kim also owns 298,427 shares of Zymergen Inc (ZY) as of September 2, 2022, with a value of $725,178 and a weighting of 32.23%.
Latest Holdings of Mina Kim
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SLRN | Acelyrin Inc | 2025-03-17 | 671,753 | 2.27 | 1,524,879 |
| ZY | Zymergen Inc | 2022-09-02 | 298,427 | 2.43 | 725,178 |
Holding Weightings of Mina Kim
Mina Kim Form 4 Trading Tracker
According to the SEC Form 4 filings, Mina Kim has made a total of 2 transactions in Acelyrin Inc (SLRN) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in Acelyrin Inc is the sale of 17,986 shares on March 17, 2025, which brought Mina Kim around $49,282.
According to the SEC Form 4 filings, Mina Kim has made a total of 5 transactions in Zymergen Inc (ZY) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in Zymergen Inc is the sale of 3,410 shares on September 2, 2022, which brought Mina Kim around $7,536.
Insider Trading History of Mina Kim
- 1
Mina Kim Trading Performance
GuruFocus tracks the stock performance after each of Mina Kim's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Mina Kim is 3.28%. GuruFocus also compares Mina Kim's trading performance to market benchmark return within the same time period. The performance of stocks bought by Mina Kim within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Mina Kim's insider trading performs compared to the benchmark.
Performance of Mina Kim
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -24.26 | | | | | |
| Relative Return to S&P 500(%) | -28.62 | | | | | |
Mina Kim Ownership Network
Ownership Network List of Mina Kim
Ownership Network Relation of Mina Kim
Mina Kim Owned Company Details
What does Atara Biotherapeutics Inc do?
Who are the key executives at Atara Biotherapeutics Inc?
Mina Kim is the Senior VP & General Counsel of Atara Biotherapeutics Inc. Other key executives at Atara Biotherapeutics Inc include EVP & Chief Sci. & Tech Officer Anhco Nguyen , EVP & Global Head RA & Quality Jill Henrich , and SVP & CFO Eric J Hyllengren .
Atara Biotherapeutics Inc (ATRA) Insider Trades Summary
Over the past 18 months, Mina Kim made no insider transaction in Atara Biotherapeutics Inc (ATRA). Other recent insider transactions involving Atara Biotherapeutics Inc (ATRA) include a net sale of 63,737 shares made by Anhco Nguyen , a net sale of 38,972 shares made by Eric J Hyllengren , and a net sale of 32,651 shares made by Jill Henrich .
In summary, during the past 3 months, insiders sold 5,494 shares of Atara Biotherapeutics Inc (ATRA) in total and bought 0 shares, with a net sale of 5,494 shares. During the past 18 months, 33,869 shares of Atara Biotherapeutics Inc (ATRA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 33,869 shares.
Atara Biotherapeutics Inc (ATRA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Atara Biotherapeutics Inc Insider Transactions
Mina Kim Mailing Address
Above is the net worth, insider trading, and ownership report for Mina Kim. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Mina Kim's mailing address is: Agoura Hills Ca 91301.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
